News

Oxford COVID-19 vaccine enters human trial stage

University of Oxford researchers have begun testing a COVID-19 vaccine in human volunteers in Oxford.

Read More

Apr 24, 2020

By : Team ABLE

BioNTech and Pfizer to initiate first COVID-19-related clinical trial in Germany

BioNTech and Pfizer are jointly developing BNT162. The trial is the first clinical trial of a COVID-19 vaccine candidate to start in Germany, and is part of a global development program.

Read More

Apr 24, 2020

By : Team ABLE

Bugworks raises $7.5 millionfrom a Global Investment Syndicate to fight against Deadly Bacterial Superbugs

Bugworkshas raised $7.5 million from a Global Investment Syndicate to combat the global challenge posed by deadly bacterial superbugs.

Read More

Apr 23, 2020

By : Team ABLE

DST supported NGO network tackle COVID-19 at community level through S&T interventions

Apart from preventing COVID-19 infection, these interventions have also provided an alternate source of livelihoods for women SHGs.

Read More

Apr 23, 2020

By : Team ABLE

Agharkar Research Institute scientists develop microreactor for uniform size-nanoparticles

Scientists from Agharkar Research Institute have developed a microreactor that can produce large quantities of uniform size nanoparticles serving a major requirement in biomedical technology.

Read More

Apr 23, 2020

By : Team ABLE

 

Exhibit in the 'India Pavilion' at BIO 2026

June 22-25 | San Diego, USA

Indian Startup Delegations to the USA & UK

Applications Open

Focus Areas

Highlights